Nitrostat and Feldene drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nitrostat (nitroglycerin) and Feldene (piroxicam). Common drug interactions include arterial occlusive disease among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Nitrostat and Feldene. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Nitrostat?

Nitrostat has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 14,082 Nitrostat users. Check the latest studies of Nitrostat.

What is Feldene?

Feldene has active ingredients of piroxicam. It is often used in arthritis. eHealthMe is studying from 3,913 Feldene users. Check the latest studies of Feldene.



On Aug, 12, 2026

16 people who take Nitrostat and Feldene together, and have interactions are studied.

Nitrostat and Feldene drug interactions.

What are the common drug interactions of Nitrostat and Feldene, by gender? *:

female:

  1. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  2. Body height decreased
  3. Breast cancer
  4. Breast haemorrhage (bleeding in breast)
  5. Cardiac failure congestive
  6. Cardiomegaly (increased size of heart than normal)
  7. Cervical vertebral fracture
  8. Constipation
  9. Cough
  10. Depression

male:

  1. Anxiety
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Arthropathy
  4. Back pain
  5. Blood creatinine increased
  6. Blood immunoglobulin g increased
  7. Bone disorder
  8. Cardiac arrest
  9. Cardiac asthma (wheezing, coughing or shortness of breath due to congestive heart failure)
  10. Cardiomegaly (increased size of heart than normal)

What are the common drug interactions of Nitrostat and Feldene, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Cardiac disorder
  2. Migraine (headache)
  3. Type 1 diabetes mellitus
  4. Cardiac failure congestive
  5. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  6. Hypoglycaemia (deficiency of glucose in the bloodstream)
  7. Joint injury
  8. Thrombosis (formation of a blood clot inside a blood vessel)
  9. Viral cardiomyopathy (weakness in the muscle of the heart due to viral infection)

30-39:

n/a

40-49:

n/a

50-59:

  1. Anxiety
  2. Feeling jittery
  3. Insomnia (sleeplessness)
  4. Jugular vein thrombosis (clot in jugular vein)
  5. Pain in extremity
  6. Peripheral swelling
  7. Restlessness (not able to rest)
  8. Skin tightness
  9. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  10. Aggression

60+:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Cardiac failure congestive
  3. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  4. Arthralgia (joint pain)
  5. Arthropathy
  6. Back pain
  7. Blood creatinine increased
  8. Blood immunoglobulin g increased
  9. Bone disorder
  10. Bone pain

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 6 people, 37.50%
  2. Stable Angina (a constant chest pain): 6 people, 37.50%
  3. Arrhythmias (irregular heartbeat): 6 people, 37.50%
  4. Depression: 6 people, 37.50%
  5. Stress And Anxiety: 3 people, 18.75%
  6. Sleep Disorder: 3 people, 18.75%
  7. Post-Traumatic Stress Disorder: 2 people, 12.50%
  8. Diabetes: 1 person, 6.25%
  9. Asthma: 1 person, 6.25%
  10. Back Disorder: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Nitrostat and Feldene?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nitrostat and Feldene:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nitrostat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Feldene:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nitrostat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Feldene and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on nitroglycerin and piroxicam (the active ingredients of Nitrostat and Feldene, respectively), and Nitrostat and Feldene (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: